| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/22/2002 | US6340579 Gene encoding an alpha-hydroxy-gamma-carboxymuconic acid-epsilon-semialdehyde dehydrogenase |
| 01/22/2002 | US6340578 High speed determination of three-dimensional structure using isotopes; polypeptide biosynthesis |
| 01/22/2002 | CA2057711C Antibiotic agent |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/17/2002 | WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 01/17/2002 | WO2002004652A1 Production of yeast involving an acclimatisation step prior to use in baking |
| 01/17/2002 | WO2002004647A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | WO2002004646A1 Expression system |
| 01/17/2002 | WO2002004642A1 Novel polypeptide and dna thereof |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004625A1 α-SYNUCLEIN BINDING PROTEIN |
| 01/17/2002 | WO2002004624A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 01/17/2002 | WO2002004619A2 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target |
| 01/17/2002 | WO2002004613A2 Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 01/17/2002 | WO2002004602A1 Transformed yeast presenting protein a on the cell surface layer |
| 01/17/2002 | WO2002004600A2 Novel compounds |
| 01/17/2002 | WO2002004599A2 Placental protein having multiple egf-like domains |
| 01/17/2002 | WO2002004523A2 Artificial antibody polypeptides |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | WO2002004512A2 Purification of human troponin i |
| 01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/17/2002 | WO2002004510A2 Gtp-binding proteins |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004496A2 Fimh adhesin proteins and methods of use |
| 01/17/2002 | WO2002004495A2 Streptococcus pyogenes antigen |
| 01/17/2002 | WO2002004493A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004485A1 Haemagglutinin antigen |
| 01/17/2002 | WO2002004022A1 High fidelity polymerases and uses thereof |
| 01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
| 01/17/2002 | WO2002003812A2 Animal feed containing polypeptides |
| 01/17/2002 | WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/17/2002 | WO2001061006A3 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 01/17/2002 | WO2001054672A3 Closure of bacterial ghosts |
| 01/17/2002 | WO2001053474A3 Flavobacterium heparinum expression system |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | WO2001036619A3 Cloning and characterization of the cap gene promoter |
| 01/17/2002 | WO2001034833A3 Regulating endogenous inhibitor at atp synthase |
| 01/17/2002 | WO2001034769A3 24 human secreted proteins |
| 01/17/2002 | WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 01/17/2002 | WO2001032830A3 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom |
| 01/17/2002 | WO2001032696A3 Traf family proteins |
| 01/17/2002 | WO2001030997A3 Microbe, microbial exopolysaccharide, and uses thereof |
| 01/17/2002 | WO2001030996A3 Microbial exopolysaccharide and uses thereof |
| 01/17/2002 | WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 01/17/2002 | WO2001023589A3 23431, a novel human ubiquitin protease |
| 01/17/2002 | WO2001023541A3 Compositions and methods for altering gene expression |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001013117A3 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | WO2000077192A9 Reg-binding protein |
| 01/17/2002 | WO2000063391A3 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 01/17/2002 | WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 01/17/2002 | US20020007501 Protein; for use in the generation of stress, insect and disease resistant plants |
| 01/17/2002 | US20020007052 Point mutations; genetic engineering; hybridization |
| 01/17/2002 | US20020007051 Producing population of hybrid nucleic acid molecules via mixing populations of nucleic acid molecules containing multiple recombination sites; genetic engineering; gene expression |
| 01/17/2002 | US20020007046 Polypeptides for use in the diagnosis, prevention and treatment of cancer and immunological defects |
| 01/17/2002 | US20020006665 Ketogulonigenium endogenous plasmids |
| 01/17/2002 | US20020006661 Controlling gene expression in living cells |
| 01/17/2002 | US20020006657 Nucleic acids which encode insect acetylcholine receptor subunits |
| 01/17/2002 | US20020006652 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/17/2002 | US20020006651 To convert ethyl 4-chloroacetoacetate using NADPH as a coenzyme to produce ethyl (S)-4-chloro-3-hydroxybutyrate; substrate specificity, no activity to ethyl acetoacetate, specified optimal pH and temperature; enzyme from candida |
| 01/17/2002 | US20020006650 Solid culture substrate including barley |
| 01/17/2002 | US20020006645 Producing (S)-4-hydroxy-2-ketoglutaric acid and compounds which are formed by biosynthesis from this precursor using recombinant microorganism carrying a recombinant DNA harboring this acid aldolase gene, sugar and glyoxylic acid |
| 01/17/2002 | US20020006641 Increasing production of proteins in gram-positive microorganisms |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006450 Improved physical properties and shelf life, in the form of powdered clathrates in which Aureobacidium culture solution as a guest is included in cyclodextrin as a host component |
| 01/17/2002 | US20020006432 Bifidobacterium in the treatment of inflammatory disease |
| 01/17/2002 | US20020006414 External composition for skin comprising sphingoglycolipid |
| 01/17/2002 | US20020006408 Vaccines against eimeria mediated disorder |
| 01/17/2002 | US20020006379 Diagnosis of tissue damage, cancer |
| 01/17/2002 | DE10032173A1 Neue für das plsC-Gen kodierende Nukleotidsequenzen New coding for the plsC gene nucleotide sequences |
| 01/17/2002 | CA2658217A1 Expression system |
| 01/17/2002 | CA2416219A1 Artificial antibody polypeptides |
| 01/17/2002 | CA2416203A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | CA2415808A1 Transporters and ion channels |
| 01/17/2002 | CA2415767A1 High fidelity polymerases and uses thereof |
| 01/17/2002 | CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | CA2415483A1 Antisense compositions targeted to .beta.1 adrenoceptor-specific mrna and methods of use |
| 01/17/2002 | CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors |
| 01/17/2002 | CA2415382A1 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target |
| 01/17/2002 | CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 01/17/2002 | CA2415127A1 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | CA2414460A1 Fimh adhesin proteins and methods of use |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2414374A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/17/2002 | CA2413810A1 Aminoacyl trna synthetases |